MEET NICLOSAVIR
Dedicated to Improving the Health and Wellbeing
of Animals and People
Principal Focus
Discovering New Therapies for Infectious Diseases
The Niclosavir team has successfully re-purposed an existing drug so that is able to become an effective therapeutic to address key health challenges in both humans and animals. The principal focus is on developing a new treatment for mastitis in dairy cows
Niclosavir is the result of breakthrough research into an old drug, niclosamide, discovered in the 1950s as a treatment for tapeworms in animals and humans. The team at Niclosavir has developed a unique formulation permitting the drug to be repurposed into an effective therapeutic enabling its medical potential and anti-infectious properties to be developed.
​
Importantly, there is now a drive in the dairy industry to reduce the use of antibiotics and this is why Niclosavir has focused on developing a product that is not an antibiotic and is able to support this drive to protect the effectiveness of antibiotics for human diseases.
The team at Niclosavir are focused on bringing their proprietary formulation to control Mastitis and improve on the current methods for treating this disease.
